Get started
Author

Ronan Le Calloch

Observed names: Le Calloc'H, Ronan, Le Calloch R, Le Calloch Ronan, R Le Calloch, R. Le Calloch, R. Le Calloc’h, Ronan LE CALLOCH, Ronan LE Calloc'h, Ronan Le Calloch
ORCID: 0000-0001-5883-1825
Observed ORCID: 0000-0001-5883-1825
OpenAlex ID: A5020551031
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
2018 · David Ghez, Anne Calleja, et al. · Blood · 321
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
2024 · Xavier Leleu, Cyrille Hulin, et al. · Nature Medicine · 144
PDF
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
2020 · Kamel Laribi, Alix Baugier de Materre, et al. · Blood Advances · 92
PDF
Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study
2018 · Lenaïg Le Clech, Jean-Philippe Talarmin, et al. · Scandinavian Journal of Infectious Diseases · 83
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older
2021 · Lucie Oberic, Frederic Peyrade, et al. · Journal of Clinical Oncology · 78
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
2018 · Kamel Laribi, Stéphanie Poulain, et al. · British Journal of Haematology · 66
PDF
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM
2024 · Florent Malard, Arthur Bobin, et al. · Blood Cancer Journal · 30
PDF
Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase
2018 · Lise-Marie Mollard, Aurélie Chauveau, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 25
Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization ( FILO )
2024 · Kamel Laribi, Stéphanie Poulain, et al. · British Journal of Haematology · 22
Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients
2011 · J-C Ianotto, A Tempescul, et al. · Bone Marrow Transplantation · 22
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
2023 · Alexis Talbot, Arthur Bobin, et al. · Haematologica · 20
PDF
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
2022 · Raphaelle Aubrais, Krimo Bouabdallah, et al. · Blood Advances · 20
PDF
Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review
2018 · Hélène Babey, Gilles Quéré, et al. · Expert Review of Anticancer Therapy · 19
Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?
2018 · E. Gaye, A. Le Bot, et al. · Médecine et Maladies Infectieuses · 18
Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature
2019 · Nicolas Gendron, Flore Sicre de Fontbrune, et al. · Haematologica · 15
PDF
Ibrutinib, Venetoclax Plus CD20 Monoclonal Ab Provides Very High MRD Negativity in Previously Untreated MCL Patients, Initial Results of OASIS II, a Randomized Phase 2 Trial
2024 · Steven Le Gouill, Virginie de Wilde, et al. · Blood · 12
PDF
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
2020 · Sophie Vantyghem, Pierre Peterlin, et al. · Haematologica · 12
PDF
Lymphomas with kidney involvement: the French multicenter retrospective LyKID study
2020 · Milena Kohn, Alexandre Karras, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis
2019 · Christelle Le Gall‐Ianotto, Ronan Le Calloch, et al. · Journal of Thrombosis and Haemostasis · 12
Dose-Intensity Impacts On Survival of Adolescents and Young Adults with Acute Lymphoblastic Leukemia Treated in Adult Departments by a Pediatric Protocol (FRALLE 2000BT)
2012 · Thomas Cluzeau, Nathalie Dhedin, et al. · Blood · 12
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
2017 · Ronan Le Calloch, Karine Lacut, et al. · Haematologica · 11
PDF
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
2024 · Caroline Dartigeas, Anne Quinquenel, et al. · Annals of Hematology · 10
PDF
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
2022 · Kamel Laribi, Alix Baugier de Materre, et al. · HemaSphere · 10
Large B-cell lymphoma: The LYSA pragmatic guidelines
2025 · Pierre Sesques, Guillaume Manson, et al. · European Journal of Cancer · 7
PDF
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm
2022 · Ronan Le Calloch, Bertrand Arnaud, et al. · Annals of Hematology · 7
Works count: 74
Citation count: 1,141
H-index: 15
I10-index: 23
Year
Topic
Type